Berman Capital Advisors, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$11,000
-38.9%
261
-21.4%
0.00%
-33.3%
Q2 2021$18,000
-25.0%
3320.0%0.00%
-40.0%
Q1 2021$24,000
-14.3%
3320.0%0.01%
-28.6%
Q4 2020$28,000
+40.0%
3320.0%0.01%
+16.7%
Q3 2020$20,000
+100.0%
332
+28.7%
0.01%
+100.0%
Q2 2020$10,000
+900.0%
258
+616.7%
0.00%
Q1 2020$1,000
-66.7%
36
+28.6%
0.00%
-100.0%
Q3 2019$3,000
-40.0%
280.0%0.00%
-50.0%
Q2 2019$5,000
+25.0%
280.0%0.00%
+100.0%
Q1 2019$4,000280.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders